(Q48481233)

English

In vivo and in vitro pharmacologic profile of two new irreversible MAO-B inhibitors: MDL 72,974A and fluorodeprenyl

scientific article published in May 1992

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1637071

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/1637071

title

In vivo and in vitro pharmacologic profile of two new irreversible MAO-B inhibitors: MDL 72,974A and fluorodeprenyl (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1637071

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/1637071

author name string

Terleckyj IA

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1637071

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/1637071

Heikkila RE

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1637071

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/1637071

language of work or name

English

0 references

publication date

1 May 1992

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1637071

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/1637071

published in

Annals of the New York Academy of Sciences

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1637071

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/1637071

volume

648

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1637071

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/1637071

page(s)

365-367

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1637071

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/1637071

cites work

MDL 72,974: a potent and selective enzyme-activated irreversible inhibitor of monoamine oxidase type B with potential for use in Parkinson's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24584.X

retrieved

21 January 2018

Identifiers

DOI

10.1111/J.1749-6632.1992.TB24584.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1637071

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/1637071

PubMed publication ID

1637071

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1637071

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/1637071

(Q48481233)

In vivo and in vitro pharmacologic profile of two new irreversible MAO-B inhibitors: MDL 72,974A and fluorodeprenyl

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)